Your browser doesn't support javascript.
loading
A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides.
Jen, Freda E-C; El-Deeb, Ibrahim M; Zalucki, Yaramah M; Edwards, Jennifer L; Walker, Mark J; von Itzstein, Mark; Jennings, Michael P.
Afiliação
  • Jen FE; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland 4222, Australia.
  • El-Deeb IM; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland 4222, Australia.
  • Zalucki YM; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland 4222, Australia.
  • Edwards JL; The Center for Microbial Pathogenesis, The Abigail Wexner Research Institute at Nationwide Children's Hospital and The Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
  • Walker MJ; School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • von Itzstein M; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland 4222, Australia.
  • Jennings MP; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland 4222, Australia.
J Antimicrob Chemother ; 76(11): 2850-2853, 2021 10 11.
Article em En | MEDLINE | ID: mdl-34450628

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Gonorreia / Doença de Huntington / Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Gonorreia / Doença de Huntington / Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article